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and Joanna Szmydynger-Chodobska1*Abstract
In June 2014 Dr. Joseph D. Fenstermacher celebrated his 80th birthday, which was honored by the symposium
held in New London, NH, USA. This review discusses Fenstermacher’s contribution to the field of fluids and barriers
of the CNS. Specifically, his fundamental work on diffusion of molecules within the brain extracellular space and the
research on properties of the blood–brain barrier in health and disease are described. Fenstermacher’s early
research on cerebrospinal fluid dynamics and the regulation of cerebral blood flow is also reviewed, followed by
the discussion of his more recent work involving the use of magnetic resonance imaging.
Keywords: Cerebrospinal fluid, Brain extracellular space, Ventriculocisternal perfusion, Diffusion, Radiolabelled
tracers, Cerebral blood flow, MRI contrast agent, Tumour therapyIntroduction
In June of 2014 a symposium was held in New London,
NH, USA to celebrate the 80th birthday of Dr. Joseph D.
Fenstermacher and to highlight his exceptional contri-
bution to the field of fluids and barriers of the CNS.
Over the past 50 years remarkable progress has been
made in our knowledge of the function of the blood–
brain barrier (BBB) and blood-cerebrospinal fluid barrier
(BCSFB), and physiology of extracellular fluids in the
brain. The work of Joseph Fenstermacher, his students,
and his colleagues was instrumental in providing the
basis for our current understanding of these aspects of
brain function.
In this article, we will discuss Fenstermacher’s contribu-
tion to the field, and also reflect on how his early work and
the experimental tools at his disposal allowed him to de-
scribe the physiological phenomena. We also show that with
the help of modern research technologies, these can now be
confirmed with an improved understanding. This review
will start with a section written by Charles Nicholson* Correspondence: Joanna_szmydynger-chodobska@brown.edu
1Department of Emergency Medicine, Neurotrauma and Brain Barriers
Research Laboratory, The Warren Alpert Medical School of Brown University,
Coro Center West, Room 112, 1 Hoppin Street, Providence, RI 02903, USA
Full list of author information is available at the end of the article
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reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.introducing the reader to Fenstermacher’s early work on dif-
fusion of radiotracers within the brain extracellular space
(ECS) and the assessment of its volume fraction. The next
section, written by Adam Chodobski and Jean-François
Ghersi-Egea, will focus on early investigations of cerebro-
spinal fluid (CSF) formation and space, followed by early
studies of the regulation of cerebral blood flow (CBF). The
final part, written by Tavarekere Nagaraja, will be devoted to
the last seventeen years of Fenstermacher’s work during
which he and his colleagues validated modern technologies
such as magnetic resonance imaging (MRI) by concurrently
employing previously established radioisotopic techniques.Review
Ventriculocisternal perfusion applied to the study of
diffusion in ECS
The ECS is the totality of the narrow gaps that separate
adjacent cells of the brain. In the 1950’s and 1960’s there
was much controversy about this domain. The width of
the ECS was thought to be much less than a micrometer;
nonetheless, because a tiny atmosphere of ECS surrounds
each cell membrane and there are a huge number of cells,
the fraction of brain tissue occupied by ECS (volume frac-
tion) could be appreciable. The problem in the early days
was to assign a numerical value to the volume fractiontral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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were the electron microscopists who obtained different,
and usually small, values depending on how they eutha-
nized the animals and fixed the tissue, because the width
of the ECS is exceedingly sensitive to ischemia and the
water content of the cells [1]. On the other side were the
physiologists who bathed a volume of tissue in a small ra-
diotracer that was supposed to permeate only the ECS,
and then measured how much had equilibrated with the
total tissue volume [2]; unfortunately, many tracers used
are far from impermeable.
As is often the case when the topic engenders heated
discussion, the resolution required a better technique
and this duly appeared in the form of ventriculocisternal
perfusion with radiolabeled inulin (Figure 1A). Rall,
Oppelt and Patlak [3] used this method to establish the
volume fraction of the ECS in the caudate nucleus of
mongrel dogs. They based their results on tissue samples
taken at different time points from the first few millime-
ters from the ventricle. Because they took samples all
the way through the thickness of the caudate and cortex,
the figure in their paper clearly shows that they hadFigure 1 Diffusion measurements using ventriculocisternal perfusion.
Physiological saline containing radiotracer enters via the INFLOW cannula,
via the OUTFLOW cannula (Modified from [8]). B. Typical locations of samp
Right lateral ventricle (r.l.v.) is flushed with radiolabelled inulin (at concentra
C0 recovered after 3–5 hours through caudate nucleus (c.n.) and cortex. No
tracer perfuses the subarachnoid space, (modified from [3]). C. Relative con
perfusion with radiolabelled inulin. Profiles shown in caudate nucleus and
comparison. Note that diffusion in the brain is more hindered than in agar
calculated using Eq. (1), (modified from [7]). D. Diagram of pathways that a
ventricular surface. Inulin and sucrose remain in the ECS but mannitol ente
barrier into blood vessels (b.v.). Water is not confined to the ECS but excha
Abbreviations: b.v.: blood vessel; c. magna: cisterna magna; c.n.:caudate nuc
subarachnoid space.established a gradient of concentration (Figure 1B). Such a
gradient is a characteristic of diffusion and a measurement
of the gradient has the potential to yield the effective dif-
fusion coefficient for the substance of choice in the tissue.
A subsequent paper by Oppelt and Rall [4] exploited this
concept to make some of the first estimates of volume
fraction and effective diffusion coefficients, primarily using
inulin and sucrose in several brain regions and animal
species, including: “live dog, dead dog, live cat, dead cat,
live green monkey, dead green monkey, live rhesus mon-
key, dead rhesus monkey”.
After the ventriculocisternal perfusion method be-
came established there was a need to refine it and ex-
pand the work. This is where Fenstermacher appears in
the publications with this method. In fact, he had made an
earlier attempt to measure ECS volume fraction using
subarachnoid perfusion but the results gave a low value,
which even the authors themselves questioned [5]. The
paper by Fenstermacher, Rall, Patlak and Levin [6] is pri-
marily about the application of the ventriculocisternal per-
fusion method and it further established that sucrose and
inulin were good ECS molecules for studying diffusion inA. Diagram of ventriculocisternal perfusion system in sagittal view.
flows predominantly through the lateral, III, and IV ventricles and leaves
les of radiotracer recovered from fixed dog brain in coronal section.
tion C0, see Eq. (1)). Numbers in each square represent percentage of
te that tracer count increases towards cortical surface because some
centration profiles in cat brain after 132 minutes of ventriculocisternal
cortex together with profiles in 2% agar gel at the same time for
. From curves like these the effective diffusion coefficients may be
molecule may follow after entering the brain from the CSF at a
rs neurons and glia to some extent and also crosses the blood–brain
nges with other compartments relatively freely, (modified from [6].
leus; ep: ependymal cell; r.l.v.: right lateral ventricle; s.a.s.:
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used the technique to make extensive measurements of
ECS volume fraction in rabbits, cats, dogs and monkeys.
They concluded that the volume fraction (α) in the cerebral
cortex, averaged across all four species, was 19.7% for su-
crose and 18.3% for inulin. It may be noted that the volume
fraction values are close to those reported with more recent
ion-selective microelectrode measurements that will be de-
scribed below. These investigators were also able to
make a rough estimate of the effective diffusion coeffi-
cients for these two substances based on the depth pro-
file of concentration (Figure 1C).
The parameters of the ventriculocisternal method had
become established (Figure 1A; [8]); however it took a few
years to realize fully the potential of the approach. This
became evident in two papers, one published in 1974 and
the other in 1975; indeed, in these two papers, we are no
longer talking about just diffusion but the method has been
broadened to include molecular transport at the ECS inter-
faces. In Fenstermacher, Patlak and Blasberg [9] a new level
of sophistication was reached: working on the dogfish at
the Mount Desert Island Biological Laboratory, the ventri-
culocisternal perfusion method was extended to determine
the transfer constants at the ependymal layer of the ventri-
cles and at the capillary level of the BBB while taking into
account possible equilibration between extra- and intracel-
lular spaces. This short paper did not fully describe the
equations involved but these appear in detail in Patlak and
Fenstermacher [10], which may be one of the crowning
achievements of this era of diffusion studies.
The 1975 study returned to the dog and focused on
caudate nucleus and cortex, measuring all the parameters
outlined in the 1974 paper. In addition, careful measure-
ments confirmed just how much the ECS hindered the
movement of a small extracellular molecule, like sucrose,
showing that its effective diffusion coefficient (Deffective)
was about 45% of the value in water. The hindrance to dif-
fusion was measured by calculating the tortuosity value, λ,
defined as λ = (D/Deffective)
1/2 where D was the free diffu-
sion coefficient. The value of λ was calculated from the
one-dimensional solution to the diffusion equation, which
in its simplest form (see Eq. 19 in [10]) is:













where C(x,t) is the concentration at depth x and time t
and C0 is concentration in the perfusate. The function
‘erfc’ is the complementary error function.
This approach gave a λ-value for sucrose of about 1.5
[10]. Effective diffusion coefficients for inulin, sucrose
and sodium are summarized in Fenstermacher andPatlak [11] confirming that the tortuosity established
with the first two molecules was 1.5. Sodium yielded a
tortuosity of 1.8, doubtless reflecting the fact that this
cation is not wholly confined to the ECS. Again, the tor-
tuosity values established with the two neutral molecules
have been confirmed by more recent measurements with
ion-selective microelectrodes. Fenstermacher and Patlak
[11] also provided an interesting discussion of bulk flow
in brain tissue – a topic that has been under discussion
for many years [12], and which has become prominent
again lately [13,14].
By 1975, it was also becoming clear that radiolabeled
sucrose was the probe of choice for a molecule that re-
mains predominantly in the ECS (inulin is less reliable).
In many practical situations, however, one wants to
study molecules that penetrate cells or move across the
BBB (Figure 1D). One example is molecules that are
used for chemotherapy in brain tissue. In one of several
studies, Blasberg, Patlak and Fenstermacher [15] applied
ventriculocisternal perfusion to the study of the diffusion
properties of five different chemotherapeutic drugs in
monkey brain and concluded that they differ in their
distribution space and capillary permeability thus show-
ing that different application regimens will be required
for effective drug application. The distribution space is
defined as the space that the molecules actually occupy;
depending on the technique used to make the measure-
ment, the volume fraction obtained may exceed unity if
molecules are actively accumulated in cells. In 1976, a
series of studies with John Kessler expanded the ventri-
culocisternal perfusion methodology to subarachnoid
perfusion in monkey spinal cord, e.g. [16], paving the
way for better drug application to this important part of
the CNS. The studies on the spinal cord lacked some of
the precision seen in the cortex, doubtless because the
small cross-section of the spinal cord does not lend itself
well to perfusion studies.
This brief survey of Fenstermacher’s considerable impact
on the quantitative analysis of diffusion has recognized his
pioneering contributions but omitted many relevant papers.
For a more extensive, though also not complete, summary
of the radiotracer work see Fenstermacher and Kaye [17].
The point-source paradigm for ECS diffusion measurements
One of the advantages of ventriculocisternal perfusion
with radiotracers is that it may be used with a wide variety
of substances subject only to the condition that they can
be formulated as a radiotracer. There are significant disad-
vantages to the method, however. Only one time-point
can be obtained per animal and the blocks of tissue har-
vested to determine concentration must be sufficiently
large to achieve an accurate reading, which limits spatial
resolution and promotes the use of large brains and con-
sequently, large animals, such as dogs. Only tissue fairly
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broadly conform to a one-dimensional diffusion problem.
This also implies that the tissue under analysis must be
homogeneous in structure. Finally, radioactive substances
must be used with their attendant practical issues.
Some of the disadvantages of the radiotracer method
were overcome through the introduction of the ‘point-
source paradigm’ by Charles Nicholson and co-workers.
The idea is simply to release a substance from a micropip-
ette and then measure the concentration as a function of
time and distance, fit the appropriate solution of the diffu-
sion equation and extract α and λ (Figure 2A). The first de-
tailed implementation of this concept was by Nicholson
and Phillips [18] where both small cations and anions were
employed. The ion of choice was released by iontophor-
esis from a micropipette located in the brain and theFigure 2 Diffusion measurements using point-source paradigm and a
measurements using RTI and IOI methods. Either a brain slice (shown here) o
For RTI, TMA+ is iontophoresed from the injection micropipette and detected
is digitized and converted to concentration-versus-time using a personal com
and α are measured. For IOI, a fluorescent molecule, (3 kDa MW dextran
a 10× objective (obj.) and a charge-coupled device (CCD) camera. A solution
and Deffective extracted. B. Diffusion curves with TMA
+ in normal and thick rat
(400 μm) slices typical values of λ and α were measured. In thick slices (1000 μ
(modified with permission from [24]). C. Monte Carlo computer simulation
tissue modeled from cubes surrounded by a thin atmosphere of ECS an
three cubes and associated ECS creating a dead-space. Volume fraction was va
show simulation results and continuous lines came from Eq. (4) with β = 3. Mo
using cells without cavities also shown (modified with permission from [34]).concentration measured as a function of time about 100 μm
away using an ion-selective microelectrode. Subsequently,
tetramethylammonium (TMA+) was used almost exclusively
as the probe ion and the method became known as the Real
Time Iontophoretic (RTI) method or TMA method. The
technique was refined to allow for a small amount of loss of
TMA+ [19] and also to permit ions to be delivered by pres-
sure injection from a micropipette (the Real Time Pressure
or RTP method). The basic equation for the RTI method,
omitting terms for loss, is:











where C(r,t) is the concentration at radial location r
from the source micropipette and Q is the sourcemodel of extracellular space. A. Recording setup for diffusion
r anesthetized animal rests on the stage of a compound microscope.
with an ISM about 100 μm away. The resulting voltage-versus-time curve
puter (PC). By fitting Eq. (2) or a related equation, Deffective (and hence λ)
here) is pressure injected and a time-series of images captured using
of the diffusion equation (similar to Eq. (3)) is fitted to the intensity profiles
cortical slices. Separation between source and ISM was 100 μm. In normal
m), representing ischemic brain tissue, λ increased and α decreased,
of diffusion in 3D medium containing concave dead spaces. Brain
d with a cubic cavity at one corner. This cavity was surrounded by
ried from 0.05 to 0.90 with αC equal to 0.05, 0.10, and 0.20. Filled symbols
dified Maxwell relationship (Eq. (4) with αC = 0) derived from simulations
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transport number. This equation also only describes the
rising phase of the curve while the current is applied
(Figure 2A,B) – see Nicholson and Phillips [18], Nicholson
[19] or Syková and Nicholson [20] for more detail. For
the RTP method the basic equation, again omitting loss, is:
C r; tð Þ ¼ λ
2UCf





where a volume U of molecules at concentration Cf is
released instantaneously from the micropipette. See
Nicholson [21] and Syková and Nicholson [20] for
more detail.
The RTI method has been used extensively by the
Nicholson laboratory in New York with emphasis on the
normal brain and by Eva Syková and colleagues in
Prague, where many pathophysiological states have been
investigated (for a comprehensive review see Syková and
Nicholson [20]). The RTI-TMA method has amply con-
firmed the earlier studies by Fenstermacher and colleagues
using sucrose or inulin; however, the RTI method has per-
mitted studies with much higher spatial and temporal
resolution so that, for example, anisotropic [22] and in-
homogeneous properties [23] could be determined and
the behavior of the ECS quantified in ischemic tissue
(Figure 2B; [24,25]).
The main limitation of the RTI and RTP methods is
that the sensor is an ion-selective microelectrode so the
method is constrained to a few select substances of low
molecular weight (MW). It is thus best thought of as a
probe of the structure of the ECS, as encapsulated in α
and λ, although the method has been used to explore
the interaction of Ca2+ with the extracellular matrix
[26]. To extend the point-source paradigm to a wider
variety of molecules, Nicholson and Tao introduced the
Integrative Optical Imaging (IOI) method [27]. In this
method, a fluorescent macromolecule was released from a
micropipette by a brief pulse of pressure and the resulting
cloud of diffusing molecules was imaged with a standard
epifluorescence microscope. At a sequence of times, the
solution to the diffusion equation as a function of distance
(a Gaussian curve, see Eq. (3) as described for the RTP
method) was fitted to fluorescence intensity and the tortu-
osity measured (Figure 2A). The method is not able to
measure volume fraction because, unlike the iontopho-
retic method, the number of ejected molecules cannot be
precisely controlled. The measurement of λ for a variety
of molecules, including dextrans and albumins, has
proved to be interesting and shown that λ increases with
molecular weight rising from a typical value of 1.6 for
TMA+ (measured with RTI) to greater than 2 for
70,000 MW dextran or 66,000 MW bovine serum albumin
[20]. The method has even permitted the width of theECS to be estimated as between 40–60 nm, using quantum
dots [28]. The IOI approach has also revealed how proteins
like lactoferrin interact with the heparan sulfate com-
ponent of the extracellular matrix [29].
Diffusion studies are now a valuable adjunct in multi-
modal studies of function. For example, the RTI method
has revealed that the ECS expands during sleep to facili-
tate the removal of waste products [14] and most recently
both the RTI and IOI methods have helped elucidate the
role of the extracellular matrix component hyaluronan
and the ECS in epileptic seizures [30].
Quantitation and modeling of diffusion in the ECS
All the diffusion studies of Fenstermacher and colleagues
have relied on implicit models of diffusion in ECS. As
noted above, the way the experiments were conducted
led to diffusion in a single axis normal to the brain sur-
face that was perfused with radiotracer. This mandated a
one-dimensional solution to the diffusion equation for a
slab of tissue subject to a constant concentration at one
surface. This solution took the form of a complementary
error function (Eq. (1)) and Fenstermacher’s longtime col-
league, the late Clifford Patlak, a noted mathematician, de-
vised special graph paper, which was based on the inverse
of this function, to facilitate the analysis of early experi-
ments. Deviations from the expected straight-line solution
indicated that significant loss of the diffusing molecule
from the ECS was taking place, through intracellular accu-
mulation for example [15]. Another source of loss might
occur across the BBB and this was modeled in the paper
by Patlak and Fenstermacher [10]. It is worth noting the
many important contributions of Patlak to the quantitative
interpretation of diffusion in the brain; a study of Ca2+ dif-
fusion in normal and thick slices [31] probably represents
the most sophisticated analysis of radiotracers to date and
may be compared with the later study using the RTP
method by Hrabětová et al. [26].
The point-source paradigm also centers on a one-
dimensional solution to the diffusion equation, but in this
case the spherical symmetry of the problem dictates that
the solution is carried out in a spherical coordinate system.
In this approach, the diffusion is not driven by a constant
concentration boundary condition, but either by a constant
flux point source (RTI) or a small bolus (less than 1 nL) of
injected substance (RTP and IOI). The very small source
enables diffusion characteristics to be determined in a vol-
ume of tissue with a characteristic length of ~100 μm and
in periods of 30–90 s.
Analysis of studies of diffusion of molecules in the
ECS has thrown light on this most inaccessible brain
compartment. Today the interpretation of the data often
involves computer models. For example it was thought
for a long time that the typical value of λ = 1.5–1.6 for
‘point’ molecules could be accounted for by the extra
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gated around cellular profiles. Detailed Monte Carlo
modeling using the MCell program (www.mcell.org)
showed, however, that the increase in tortuosity attribut-
able to this mechanism was generally less than or equal
to 1.225 [32,33]. Experiments by Hrabětová and Nicholson
[24] and further application of Monte Carlo simulation
showed that one way to increase the tortuosity was to
incorporate so-called dead-spaces into the description of
the ECS to elevate the tortuosity to the measured values.
Imagine a model brain region consisting of cubic cells with
a cubic cavity cut out from one corner (Figure 2C, inset) to
provide a dead space when all the modified cubes are
packed together. When the cubes are packed they remain
separated by extracellular space with total extracellular
volume fraction, α, of which the volume fraction of the









where β = 3 for the geometry depicted in Figure 2C. As
already noted ([26,29]), for some molecules, interaction
with the extracellular matrix may also increase tortuosity
and this too can be modeled [35].
The pathophysiology of the CSF
The diffusion of molecules within the ECS was not the
only aspect of brain fluid physiology on which Fensterma-
cher focused his research. Indeed, he also had a keen
interest in the CSF. It is quite likely that some of Fenster-
macher’s early work related to CSF function was inspired
by his interactions with neurosurgeons Thomas Milhorat
and Mary Hammock, whose primary interest was in the
pathophysiology of hydrocephalus. These were the late
1960’s and early 1970’s, and at that time ventriculocister-
nal perfusion was the technique of choice to measure the
rate of CSF formation in experimental animals. Ventricu-
lolumbar perfusion, a modification of the ventriculocister-
nal perfusion method, was sometimes used to measure
the rate of CSF production in humans. Using this tech-
nique, Fenstermacher, Milhorat, Hammock, and others
have shown that in a two-year-old child diagnosed with
choroid plexus papilloma in one of the lateral cerebral
ventricles, the removal of the tumor resulted in a consid-
erable reduction in the rate of CSF formation [36].
Initially, inulin was employed as a non-diffusible marker
for ventriculocisternal perfusion; however, concerns have
arisen that the CSF formation rate could have been over-
estimated because of some diffusional loss of inulin from
the perfusate into the brain tissue. Fenstermacher together
with Robert Curran and other colleagues approached this
problem by simultaneously using 3H- or 14C-labeled inulin
and 131I-albumin as non-diffusible markers [37]. Thesestudies clearly demonstrated an uptake of inulin by brain
tissue surrounding the cerebral ventricles and emphasized
the importance of using the high molecular weight
markers, such as albumin, in the ventriculocisternal perfu-
sion experiments. The group then went on to use Blue
Dextran 2000, with a MW of 2 × 106 Da, as a non-
diffusible marker [38]. Since then Blue Dextran 2000 has
been predominantly chosen as a marker to measure the
rate of CSF formation with the ventriculocisternal perfu-
sion technique.
Fenstermacher has also been interested in extrachoroi-
dal sources of CSF. Earlier studies had suggested that
the choroid plexus might not be the only source of CSF.
Together with Milhorat, Hammock, and others, Fenster-
macher demonstrated that in choroid plexectomized
rhesus monkeys, the production of CSF was reduced by
33–40% [39]. While these experiments supported the
extrachoroidal production of CSF, it is important to note
that plexectomy is a highly invasive procedure, which by
itself can have a significant adverse effect on brain func-
tion. Therefore, in view of our current understanding of
brain physiology, these results should be interpreted
with caution. In a later study [38], using the ventriculo-
lumbar perfusion technique in rhesus monkeys, Fenster-
macher together with Warren Lux showed that CSF is not
produced within the spinal subarachnoid space. Working
together with Victor Levin and other colleagues on a mon-
key model of acute obstructive hydrocephalus [40,41],
Fenstermacher has also shown that non-communicating
hydrocephalus is associated with a significant expansion
of the ECS in the periventricular white matter, whereas
the production of CSF is unchanged under these patho-
logical conditions.
The collaboration with Daniel Gomez, Gordon Potts,
and others resulted in important insights into the CSF
absorption pathways, [42,43]. Using horseradish peroxid-
ase as a tracer, the group demonstrated the involvement
of the lymphatic system in bulk CSF absorption. This
provided evidence for the complexity of CSF absorption
process and allowed later on for a better understanding
of the pathophysiology of neuroinflammatory diseases.
The anatomy and physiology of CSF compartments in the
brain
His long-lasting interest in CSF physiology prompted
Fenstermacher to investigate the peculiar tracer diffusion
phenomena that were often observed in autoradio-
graphic studies in the vicinity of fluid-filled spaces in the
brain, the areas generally discarded from the analysis in
most studies. He undertook an effort to track the flow of
CSF and the fate of CSF-borne substances. His group
combined cerebroventricular infusion of polar tracers
that did not cause any disturbance in CSF flow with
quantitative autoradiography (QAR) that involved brain
Chodobski et al. Fluids and Barriers of the CNS 2015, 12:1 Page 7 of 18
http://www.fluidsbarrierscns.com/content/12/1/1tissue sampling from the frozen head to keep all fluids in
place. This allowed the group to analyze the complex CSF
circulatory system of cisternal and subarachnoid compart-
ments, including the routes of CSF flow through the cis-
terns of the velum interpositum and anterior medullary
velum. Together with his colleagues, Fenstermacher gen-
erated the tracer concentration-time profiles for multiple
compartments and described a dual physiological role of
glia limitans both in restricting the rate of tracer diffusion
into neuropil and in acting as a reservoir for solutes car-
ried by the CSF [44]. He also delineated the movement of
CSF-borne tracers within the arterial/arteriolar perivascu-
lar spaces [44], supporting the pioneering work of Helen
Cserr on the drainage of brain interstitial fluid along the
Virchow-Robin perivascular spaces [45,46]. In particular,
Fenstermacher showed that the movement of solutes oc-
curs from ventricle-to-interstitium-to-perivascular space.
He also provided the tracer-based functional evidence for
differences in perivascular anatomical organization and
local perivascular flow along the cerebral arterioles and
venules that had previously been discovered by Roy
Weller’s group [47]. This paved the way to further stud-
ies of the role of brain fluids in the elimination of po-
tentially deleterious endogenous metabolites. Applying
the previously used techniques to study the clearance
of CSF-borne substances from the brain, Fenstermacher
together with the Blas Frangione group from New York
University showed a biphasic CSF clearance rate for
amyloid-β peptide1–40 [48]. While moving along the ven-
tricular system, this peptide was initially rapidly cleared,
which was proposed to occur across either the BBB or
the BCSFB in the choroid plexus. This hypothesis has
later been tested by his and other laboratories [49,50]. After
an initial rapid phase of clearance from the CSF, the elim-
ination of amyloid-β peptide1–40 was slower when this pep-
tide was moving through the subarachnoid/cisternal spaces
to be eventually retained around pial arteries and arterioles
(Figure 3). More recently, the role of the peculiar anatom-
ical organization of CSF compartments and interconnected
perivascular spaces in the clearance of amyloid-β peptide
has been revisited. In these studies, a new brain imaging
methodology was used and new hypotheses concerning the
pathophysiology of Alzheimer’s disease were proposed
[13,14]. The detailed description of CSF flow pathways also
had an impact on the research on neuroinflammation. In
fact, the choroid plexus together with the subarachnoid
and cisternal fluid spaces described by Fenstermacher and
his colleagues are now considered to be key players in both
normal neuroimmune surveillance and pathological neuro-
inflammation [51-56].
Studies on the clearance of CSF-borne substances
from the brain were continued in Fenstermacher’s
laboratory at the Henry Ford Hospital in Detroit,
Michigan. Using 125I-insulin-like growth factor-1 (IGF1)as a tracer for this growth factor, the group demonstrated
in a rat model that the entry of IGF1 into normal brain par-
enchyma after its intracerebroventricular administration
was limited by a rapid clearance from CSF and brain, and
by slow diffusion into the periventricular brain tissue [57].
Apart from these observations, two more novel facts were
reported in this study. The first one was the deceptively
similar-shaped temporal plasma profiles of radioactivity fol-
lowing both properly performed intracerebroventricular
and erroneous intraparenchymal injections of the tracer.
The second was the construction by Patlak of an ‘emer-
gence function’ that could be used to estimate the rate of
appearance of the tracer in the venous system.
Another interesting work concerning the elimination of
CSF-borne substances, particularly drugs, was done in col-
laboration with David Smith and Richard Keep from the
University of Michigan, Ann Arbor [58]. The purpose of
these studies was to define the kinetics of CSF clearance,
choroid plexus uptake, and parenchymal penetration in
various brain regions of substrates for an oligopeptide
transporter PEPT2 (SLC15A2) following their intra-
cerebroventricular administration. PEPT2 is a high-affinity,
low-capacity carrier belonging to the family of proton-
coupled oligopeptide transporters. It is expressed at the
apical surface of the choroid plexus epithelium as well as in
astrocytes (newborn rats) and neurons (newborn and adult
rats). Residing at the BCSFB, PEPT2 plays a significant role
in limiting the brain exposure to CSF-borne peptides and
peptide-like drugs by transporting these substances out
across the BCSFB. These studies demonstrated that the
deletion of the Pept2 gene in mice significantly modifies the
spatial distribution of glycylsarcosine (GlySar) and cefa-
droxil (and presumably other peptides and peptide-like
drugs) in brain at the CSF-choroid plexus interface,
ependyma, and the septum. The penetration of the
periventricular brain tissue by 14C-GlySar in PEPT2-
null mice significantly differed from that observed in wild-
type animals, providing evidence for the importance of
PEPT2 in parenchymal drug distribution. This was the first
study to demonstrate an uptake and retention of a PEPT2
substrate in the choroid plexus tissue in all four cerebral
ventricles using QAR. Thus, combining the gene-deletion
technology with high spatial resolution QAR proved to be a
valuable approach for studying the role of brain barriers
in the regional distribution of drugs in the brain.
The physiology of the BBB
From early on in his scientific career, Joseph Fenstermacher
had a significant interest in physiology of the BBB. In his
first study published together with John Johnson [59], he
assessed basic properties of the BBB, such as the filtra-
tion and reflection coefficients, for water and several
solutes, including glucose, sucrose, and urea. Later on
Fenstermacher teamed up with Patlak to measure the
Figure 3 Distribution of CSF-borne substances within the brain. A. The autoradiogram shows the CSF-brain distribution of 125I-labeled soluble
amyloid β-peptide (I-sAβ) 30 min after unilateral intracerebroventricular administration. The radioactive material was mostly visible around pial vessels
(arteries) within the interpeduncular, ambient and quadrigeminal cisterns. The appreciable amounts were also present in the lateral recesses of the
fourth ventricle (not shown) and along the ventral wall of the aqueduct. B. The histological microphotograph of adjacent coronal section of the brain
with attached pituitary gland (Hip–hippocampus; SC - superior colliculus; V–large central vein; Pial V–small pial veins; Pial Ar–pial arteries; Aq–aqueduct,
(adapted with permission from [48]).
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utes using the ventriculocisternal perfusion technique
in dogs [10]. It seems that for Fenstermacher it was
critically important to know all the advantages and dis-
advantages of the techniques he was using. This is
reflected by his interest in theoretical analyses, like for
example the analysis of the experimental conditions for
the measurement of the blood-to-brain transfer con-
stants that was done together with Patlak and Ronald
Blasberg [60].
Fenstermacher also spent some summers working at
the Mount Desert Island Biological Laboratory located
in charming Salisbury Cove, Maine, where he met Helen
Cserr. As mentioned above, Cserr was a pioneer in re-
search on bulk flow of interstitial fluid in the brain. Later
on she also investigated the pathophysiological mecha-
nisms underlying the brain immune response. Their col-
laboration resulted in publications analyzing the properties
of brain barriers in sharks and other marine species
[61,62]. The research performed in the same laboratory
together with Andreas Roomet provided data on CSF
production and absorption in sharks [63].The opening of the BBB in acute ischemic stroke
Previous studies had indicated that the BBB damage
after stroke not only varies in regard to its spatial distri-
bution, but also in its magnitude within a given brain
region [64]. Such information was indirectly inferred
from the differential distribution of radiolabeled tracers
with two different molecular sizes, such as sucrose and
inulin [65]. Our previous data suggested that the gadolinium-
diethylenetriaminepentaacetic acid (Gd-DTPA) enhancing
regions observed immediately after reperfusion developed
hemorrhagic transformation (HT) at 24 h post-stroke
[66]. This prompted Fenstermacher and his colleagues to
postulate that an acute extravasation of blood-borne sub-
stances must be limited by the size of the opening of the
BBB. This hypothesis was investigated in a series of innova-
tive experiments. In the first set of experiments, the trans-
vascular movement of plasma and red blood cells (RBC) in
acute stroke and 24 h after reperfusion was studied.
Classical QAR tracers available for such studies were radio-
iodinated serum albumin (RISA) and 55Fe-labeled RBC
[67]. Instead, the Fenstermacher group used a technique
previously employed in tumor blood flow experiments [68]
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binding to plasma albumin), administered together with
fluorescein isothiocyanate (FITC)-labeled autologous
RBCs. The data showed that at 3 h after reperfusion, Evans
blue leaked, but the RBCs remained intravascular, whereas
at 24 h post-reperfusion both Evans blue and RBCs were
found in the extravascular space [69], confirming the previ-
ous observations by Knight et al. [66]. The next question
to address was the maximal size of blood-borne molecules
that can extravasate acutely after ischemia. For these inves-
tigations, once again Evans blue bound to plasma albumin
was chosen as the reference tracer, which was used to-
gether with a series of FITC-labeled dextrans of varied
sizes. These studies demonstrated that FITC-dextran of
2 × 106 Da remained intravascular acutely after reperfusion,
suggesting a possible size limit for blood-borne substances
penetrating the BBB after cerebral ischemia [70].
The demonstration of variable magnitude of BBB damage
within the ischemic lesion was done later using the MRI
technique and employing for the first time Gd-DTPA and
Gd-DTPA-albumin, two contrast agents with a significant
molecular size difference [71]. Gd-DTPA-albumin was also
linked to Evans blue, enabling the fluorescent microscopic
confirmation of the patterns of magnetic resonance (MR)
distribution of Gd-DTPA-albumin. These data conclusively
proved for the first time that the BBB damage varies within
the ischemic lesion and that it could be imaged in vivo.Early studies of the endothelial barrier in brain tumors
Working at the National Cancer Institute (NCI) in Bethesda,
Maryland, Fenstermacher together with Blasberg, Peter
Molnar, and others, investigated the properties of the endo-
thelial barrier in brain tumors. Using an experimental
rat model, the group studied various brain tumors,
including the avian sarcoma virus (ASV) [72] and
ethylnitrosourea-induced tumors [73], as well as tumors
produced by intracerebral injection of RT-9 rat gliosar-
coma cells [74] or intracarotid delivery of Walker 256
rat carcinoma cells [75]. The ethylnitrosourea model
was especially useful for these studies, as it produced di-
verse tumors, including ependymomas and a variety of
glial tumors, such as gliomas, astrocytomas, oligodendro-
gliomas, and schwannomas [73]. A local unidirectional
blood-to-tissue transfer rate constant for 14C–α-aminoiso-
butiric acid (AIB) – a low molecular weight tracer – was
measured in these tumors using QAR. A significant vari-
ability in a unidirectional blood-to-tissue transfer rate
within tumors was shown, with the values of influx rate
frequently depending on the size of the tumor and its lo-
cation. However, the magnitude of the transfer rate was
generally unrelated to specific histological features of the
tumors. These studies had important translational impli-
cations for targeting brain tumors in humans.Research on regional CBF and its regulation
In 1983 Fenstermacher moved from the NCI to the State
University of New York at Stony Brook to resume his
research on CBF and the coupling of local blood flow to
metabolism in the brain. He was soon joined there by
Clifford Patlak. Fenstermacher, with his research team mem-
bers Ling Wei, Daniel Bereczki, Tada Otsuka, Jiann-Ling
Chen, Atsushi Tajima, and Franz-Josef Hans, refined
the techniques for measuring local CBF, local cerebral
glucose utilization, and the regional capillary perme-
ability coefficient and the surface area (PS) products for
various compounds. The group combined various proto-
cols of intra-arterial administration of tracers/indicators
(e.g., ramp infusion) in both awake and anesthetized rats
with either tissue sampling from discrete brain areas or
QAR. The data obtained in these experiments were ana-
lyzed using mathematical models developed by Patlak.
This work generated a vast amount of data on regional dif-
ferences in blood volume, hematocrit, CBF, and PS prod-
ucts for tracers for lipid-mediated and carrier-facilitated
transport across the BBB for 40 distinct brain regions
[67,76-80]. These results now constitute the reference data
that are invaluable in interpreting the regional differences
in various experimental settings in the field of neurobiol-
ogy. This methodology was employed to study animal
models related to toxicology (nicotine [81,82]), the effects
of anesthesia (pentobarbital [67,83]), physiological stress,
such as hypoxia [77,79] and hypercapnia [76,78], and in
some diseases, such as hypertension [80]).
A good example of research conducted at Stony Brook
was investigation into the physiological mechanisms regulat-
ing CBF. In the 1990’s a generally accepted theory was that
an increase in CBF observed in response to hypercapnia or
hypoxia resulted from the capillary recruitment rather than
an increase in blood flow through already perfused capillar-
ies. Fenstermacher and his colleagues decided to take a close
look at this controversial issue. Using 125I-labeled serum
albumin and 55Fe-labeled RBC to estimate the blood volume
in parenchymal microvessels, Bereczki et al. [78] demon-
strated that while hypercapnia – one of the major factors
regulating blood flow to the brain – caused a significant
increase in CBF, this increase was predominantly associated
with the rise in the velocity of flow of RBC and plasma
through already perfused capillaries. The data provided
evidence for only modest capillary recruitment in response
to hypercapnia. These observations were confirmed by a
later study [76] in which the PS products for 14C-iodoanti-
pyrine (IAP) and 14C-3-O-methyl-D-glucose (3OMG) were
assessed. The group has also investigated the mechanisms
underlying the hypoxia-dependent regulation of CBF. Being
another important factor controlling CBF, hypoxia too has
been shown to increase CBF mainly by increasing the velo-
city of perfusion of brain microvessels [79]. The assessment
of PS products for IAP and 3OMG performed in the
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prove the hypothesis that an increase in CBF in response to
hypoxia is associated with capillary recruitment.
In addition to brain physiology, Fenstermacher had a
deep interest in the intricacies of research techniques
used to measure blood flow to the brain. In fact, Fenster-
macher’s early involvement in the field of CBF began with
his contribution to theoretical work on CBF. Together
with Patlak, Louis Sokoloff, and other collaborators [84],
he described experimental limitations of IAP, a diffusible
indicator most commonly used to measure local CBF
by QAR. He then went on to evaluate the errors in the
measurement of CBF by the indicator fractionation and
tissue equilibration methods [85]. This theoretical work
was done together with Patlak and Blasberg.
As described above, Fenstermacher collaborated with
Blasberg, Molnar, and others to better understand the
pathophysiology of brain tumors. They not only investi-
gated the properties of the endothelial barrier in brain
tumors, but also were interested in how these tumors
are perfused. The group studied the ASV- [86] and
ethylnitrosourea-induced tumors [87], as well as tumors
produced by RT-9 rat gliosarcoma cells [88] and Walker
256 rat carcinoma cells [89]. The 14C-IAP-based QAR was
used to assess local CBF in these tumors. Similar to the
measurements of endothelial permeability to AIB in brain
tumors, these studies have demonstrated remarkable het-
erogeneity in perfusion of the tumors, with the levels of
blood flow being frequently unrelated to histological find-
ings. In addition to characterizing the blood flow patterns
in brain tumors, these studies had important therapeutic
implications. The concurrent measurement of blood flow
and capillary permeability to AIB in ASV-induced tumors
demonstrated that the capillary permeability and sur-
face area, and not tissue perfusion, determine the
blood-to-tissue influx of blood-borne materials in brain
tumors [90].
In later studies, Fenstermacher together with Paul
Gross and other colleagues has focused on analyzing
functional and structural differences in capillary endo-
thelium between various brain regions. The group
was particularly interested in circumventricular organs
(CVOs), such as the subfornical organ and median
eminence, because of their anatomical location and
distinct morphological features. While the rate of ca-
pillary blood flow to CVOs was found to be similar to
that observed in brain grey matter, Fenstermacher and
his collaborators showed that the PS product for AIB
in CVO capillaries is 300 times greater than that mea-
sured in capillaries constituting the BBB [91]. These
findings were not only consistent with morphological
features of endothelial cells forming the capillaries in
CVOs, but also supported the putative roles of CVOs
in diverse physiological regulatory processes.Concurrent application of QAR and terminal tracer
techniques with MRI and other imaging modalities
The last seventeen years of his career Joseph Fenstermacher
spent working at the Henry Ford Hospital in Detroit,
Michigan. A significant part of his work there involved
employing MRI to investigate cerebrovascular path-
ology in animal models of ischemic stroke and brain tu-
mors. Several other studies investigating the drug
distribution in the prostate gland and the theoretical
aspects of water proton tracking, as well as the analysis
of histopathological changes in ischemic brain under-
lying MRI signal changes were also done there. In all
these studies, Fenstermacher and his team used QAR
and histopathological techniques as a gold standard to
validate MR imaging signals for assessing CBF, BBB
permeability, ECS, etc. This approach aided in precise
localization and quantification of cerebrovascular path-
ology by MRI. Several ‘Aha’ moments were a part of the
scientific discussions. Over the decades Fenstermacher
and his colleagues painstakingly perfected techniques
for measuring CBF, blood-to-brain transport kinetics,
ECS, fluid bulk flow, diffusion, convection, etc., forming
the basis for imaging applications in clinical practice.
Stroke studies: CBF measurements using MRI
One of the first major undertakings was to compare two
MRI arterial spin tagging (AST) methods for estimating
CBF with the classic IAP-based QAR technique [92]. A
rat ischemic stroke model with suture occlusion of the
middle cerebral artery for 2 h was employed in these stud-
ies. This model had the advantage of producing an ex-
tended range of CBF rates for testing the sensitivity of the
measurements and a normal contralateral side for compari-
son in the same rat. Two MRI approaches were used: spin
echo (SE) and variable tip angle gradient echo (VTA-GE)
readouts. Despite the widespread use of AST-MRI tech-
niques to estimate CBF, very few studies were done till
then to compare the MRI data with established ter-
minal tracer studies. For instance, single-coil AST has
been used in the laboratory as an imaging technique for
assessing the state of cerebral perfusion in a variety of rat
models of ischemia. Questions have been raised regarding
whether it is advisable to eliminate signal from vascular
spins, whether the technique produces signal linear to flow,
and under what conditions the technique might produce
an unbiased estimate of flow. It was in this framework that
the group examined the operating characteristics of the
AST-MRI measurement across the wide range of flows.
For the AST studies, both SE and VTA-GE readings were
used to assay tissue magnetization. The aim of this study
was to determine whether there is a correlation between
CBF estimates produced by the two AST-MRI methods;
whether the CBF rates measured by either or both of the
AST-MRI methods are concordant with those determined
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methods yield robust estimates of CBF.
Nine brain regions were chosen as regions of interest
(ROIs) for CBF assessment: preoptic area, caudate-putamen,
globus pallidus, stria terminalis, piriform cortex, insular cor-
tex, parietal cortex, hindlimb and forelimb cortex, frontal
and cingulate cortex. The QAR data were acquired in two
ways: 1) Traditional field-by-field method in which each
ROI was outlined on a digitized image of the X-ray film and
a standard curve for radioactivity vs. optical density was gen-
erated from 14C standards exposed along with brain sections.
Since the imaged MRI slices were 2 mm thick, values across
5 QAR images (each from 400 μm thick brain sections)
representing the virtual 2 mm MR slice were averaged
to get a representative value. 2) Averaged method in
which the QAR film was scanned and the images repre-
senting the 2 mm MRI slice were summed digitally. A
template of the ROIs was then superimposed on this
digital image for the acquisition of CBF values. The two
sets of CBF values from these two methods were posi-
tively correlated. With this confirmation, Method (2) was
used for further testing with MR data. The results showed
that despite the 30–40-min time lag between MRI and
QAR studies, both MR techniques were fairly well corre-
lated with CBF rates calculated using IAP-QAR [93].
However, the QAR method produced slightly lower esti-
mates that were better correlated with the VTA-GE values.
Also, the correlation was better in the ischemic side than
the contralateral side. The data also suggested that the
SE-CBF estimates were better in high-flow rate ranges and
those of VTA-GE in the low-flow range. Thus, these data
indicated that using both these techniques in human
imaging would lead to superior computation of CBF varia-
tions under disease conditions.
The blood-to-brain influx of an MRI contrast agent in
ischemic stroke and the Patlak plot
The MRI-QAR correlation of CBF in stroke demonstrated
that the approach was feasible and valuable in confirming
proton MRI data. This led to the next step of evaluation
of BBB opening in stroke, its localization by contrast-
enhanced (CE)-MRI, confirmation and quantification by
an appropriate QAR technique. Such studies were essen-
tial since CE-MRI was employed to image BBB injury in
stroke, brain tumors, and other CNS diseases; however,
the quantification of BBB damage by MRI needed some
more refinement. To this end, a rat model of transient
cerebral ischemia resulting in hemorrhagic transformation
at 24 h post-stroke was chosen [66]. A 3-step series of ex-
periments was planned to accomplish the objectives.
Methods were very similar to those adopted for CBF stud-
ies, with each MRI session immediately followed by a QAR
experiment in the same rat and the data from QAR being a
gold standard to confirm the MRI results. The MRIcontrast agent used in all these studies was Gd-DTPA.
Gadolinium analogs are the most commonly used clinical
paramagnetic agents. The first QAR tracer chosen for
comparison was 14C-sucrose. The distribution of 14C-su-
crose in the brain had been previously studied by Fenster-
macher and colleagues [7-10]. The MW for 14C-sucrose
(302 Da) is close to that of Gd-DTPA (565 Da), and most
importantly, both Gd-DTPA and sucrose do not have any
known uptake mechanisms in the brain. Therefore, their
diffusion within the ECS or their back efflux to the vascula-
ture should result in identical distribution patterns enab-
ling one-to-one comparisons.
Using the above described rat stroke model, CBF, dif-
fusion weighted imaging, T2, T1 and magnetization
transfer parameters were acquired during arterial occlu-
sion and again after reperfusion. CE-MRI was performed
once at about 2.5 h after initiating reperfusion with a
Look-Locker T1-weighted imaging sequence. At the end
of the MRI session, the rat was removed from the mag-
net and infused with a 14C-sucrose step-down protocol.
Timed arterial blood samples were collected for con-
structing the time-concentration curve or arterial input
function (AIF). Rats were sacrificed and brain tissue sec-
tions along with 14C standards were used to generate
images for QAR. The blood-to-brain influx constant (Ki)
and the extravascular distribution volume (ve) were com-
puted from 14C-sucrose AIF and the brain regional con-
centrations calculated from X-ray films. While the QAR
calculations were straightforward, equivalent MRI calcula-
tions proved troublesome. The conventional convolution/
deconvolution-based Ki/K
trans estimates were inconsistent
and not in agreement with QAR estimates. As suggested
by James Ewing, one possible way to address for this dis-
crepancy was that during the MRI acquisition, the sagittal
sinus was imaged and therefore its blood contrast agent
(CA) levels were temporally measured during the Look-
Locker sequence along with tissue levels in terms of R1
(R1 = 1/T1). That was one of the many ‘Aha’ moments in
the lab when Joe Fenstermacher said: “Jim, you are de-
scribing the Patlak plot” [94,95]. Initially, for the construc-
tion of the Patlak plot, which described the blood-to-brain
compartmental tracer distributions, rats were injected
with the tracer and its AIF was measured. However, the
rats had to be sacrificed at various durations of tracer cir-
culation to assess the brain tracer levels by autoradiog-
raphy. Brain entry after various circulation periods was
then calculated and plotted with the slope of the linear
part of the resultant curve representing the influx rate
constant Ki. Now the MRI estimates of both blood and
brain concentrations of the tracer could be used to con-
struct a Patlak plot. This was reported by Ewing et al. [96]
and Fenstermacher et al. [97].
The Patlak plot was also used to investigate whether
the Gd-DTPA method would allow the group to localize
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tracer. AIB is the best existing tracer for the localization of
BBB opening and the methodology of its use was well
established [98]. A rat stroke model was employed in these
studies along with CE-MRI, and the correlation of non-
contrast-based MRI parameters, such as the magnetization
transfer and T1sat, with BBB damage was reported in two
publications by Knight et al. [99,100]. These data suggested
that the Gd-DTPA-based CE-MRI could represent a good
indicator of the BBB damage in acute stroke. Changes in
parameters, such as T1sat and T1, may also be indicative of
BBB damage due to their sensitivity to fluctuations of water
across the BBB. However, it is important to note that the
spatial resolving power of CE-MRI with a bolus CA injec-
tion is limited to large BBB lesions.
The third and final step in comparing both methodolo-
gies came with the use, for the first time, of identical
tracers in MRI and QAR studies. Gd-DTPA was used for
the CE-MRI studies, whereas its equivalent Gd-14C-DTPA
was employed for QAR. At variance with the previous
studies in which the MR data were analyzed by Patlak
plots and compared to QAR data derived using the single
time equation, both MR and QAR data from this series of
experiments were analyzed by the single time equation
[60]. These data were also compared to the values derived
from the Patlak plot. This was done to ensure that not just
the tracers, but also the analysis would be identical be-
tween the two techniques. Results showed that the regions
of BBB opening were very similar on the MRI maps and
the autoradiograms. The extravascular distribution vol-
ume was nearly identical for Gd-DTPA and Gd-14C-
DTPA, and Ki was slightly, but not significantly, higher for
Gd-DTPA vs. Gd-14C-DTPA. The Ki values were also well
correlated. When the arterial concentration-time curve of
Gd-DTPA was adjusted to match that of Gd-14C-DTPA,
the two sets of Ki values were alike and statistically com-
parable with those previously obtained from a Patlak plot.
These findings demonstrated that the CE-MRI technique
accurately measures the Gd-DTPA concentration in blood
and brain, and that the Ki estimates based on such data
are good quantitative indicators of BBB injury [101].
Separate studies in which Gd-DTPA was either injected
as a bolus or infused using the step-down infusion (SDI)
method demonstrated that the SDI method results in su-
perior signal-to-noise ratio with far brighter pixels in the
enhancing/BBB-damaged regions [102]. This method was
also advantageous in capturing the complete AIF curve
more accurately than the bolus that missed the peak CA
blood concentration. When analyzed further, it was dis-
covered that missing the peak blood concentration led to
an overestimation of plasma volume (vp) but did not seem
to affect Ki calculations [94]. Another important finding
from these experiments was that a population-averaged
AIF could be used for estimating BBB kinetics if directmeasurements were not possible in every study [94]. As
will be discussed later, direct radiotracer-based AIF mea-
surements for Gd-DTPA from these experiments were
useful for estimations of tumor vascular permeability
kinetics.
The superior contrast enhancement after SDI adminis-
tration of Gd-DTPA suggested that this might be useful
in a better demarcation of the BBB opening. This idea
was tested by CE-MRI studies using again the ischemia-
reperfusion rat model with SDI administration of Gd-
DTPA in the magnet and Gd-14C-DTPA on the table for
QAR. Identical patterns of CA blood levels were recorded
in both procedures. The normalized plasma concentration-
time integrals were identical for Gd-DTPA and Gd-14C-
DTPA, indicating that the MRI protocol yielded reliable
estimates of plasma Gd-DTPA levels [103]. In rats with
BBB opening, 14 spatially similar regions of extravascular
Gd-DTPA enhancement and Gd-14C-DTPA leakage, in-
cluding one very small area, were observed. The terminal
tissue-plasma ratios from QAR tended to be slightly higher
than those from MRI in these regions, but the differences
were not statistically significant. The MRI-derived Ki values
for Gd-DTPA closely agreed and correlated well with those
obtained for Gd-14C-DTPA. Apart from these confirma-
tions, a salient feature of these studies was that compared
to bolus injections, spatial resolving power of the SDI input
was greater with BBB openings as small as 0.5 mm3 de-
tected by CE-MRI [103]. Subsequent analysis also showed
that unlike the bolus injection, the SDI protocol allows for
the magnetic resonance contrast agent (MRCA) to spread
beyond the ischemic core [104].
Brain tumor Gadomer and Gd-BSA studies
Despite the often-observed vascular leakiness, primary
brain tumor vascular pathology differs from that of the
BBB leakage occurring in acute stroke. It is characterized
by chronically dysregulated blood flow, angiogenesis
with areas of differentiation and necrosis. In some tu-
mors, the extreme leakiness of the vessels may result in a
rapid clearance of small molecules, such as Gd-DTPA,
leading to either under- or overestimation of permeability
kinetics. Therefore, an experimental dendritic, macromol-
ecular magnetic resonance contrast agent (MMCA)
Gadomer-17 produced by Schering AG (Germany) was
used in brain tumor studies to overcome these disadvan-
tages. Gadomer-17 has a MW of 17 kDa with an effective
size nearly that of plasma albumin. As its equivalent, an-
other MMCA was prepared by linking bovine serum albu-
min (BSA) to Gd via the chelating agent DTPA. The
resultant product had a MW of about 90 kDa, with Gd:
BSA ratio of 14:1 (as opposed to Gd:DTPA ratio of 1:1 in
the Gd-DTPA complex) [68]. The contrast enhancement
patterns of Gadomer-17 and Gd-BSA were sequentially
evaluated in a rat 9L gliosarcoma model. Following
Chodobski et al. Fluids and Barriers of the CNS 2015, 12:1 Page 13 of 18
http://www.fluidsbarrierscns.com/content/12/1/1intravenous injection, the blood concentration of Gadomer-
17 fell rapidly, whereas that of Gd-BSA was almost constant
for the duration of imaging. The areas of enhancement of
both MMCAs were comparable probably owing to their
similar effective sizes. The spatial distribution of Gd-BSA
also showed a good agreement with that of Evans blue-
tagged albumin. Treatment with dexamethasone decreased
Gd-BSA enhancement in the tumor, suggesting that it can
be used to image brain tumors and their response to treat-
ment [105].
As the final confirmation of these data, the classic con-
current MRI-QAR experiments were performed using the
same tumor model. With Gd-BSA as the paramagnetic
agent, RISA was employed for QAR. Look-Locker MRI es-
timates of T1 followed Gd-BSA blood (sagittal sinus) and
tissue (ROI) concentration. QAR and MRI maps of Ktrans
were co-registered, an ROI that included the tumor and its
surrounding brain tissue was selected, and the two esti-
mates of Ktrans from the ROI on QAR and MRI maps were
compared by either mean per animal ROI or on pixel-by-
pixel data using a generalized estimating equation. Good
correlation was observed between end-point QAR values
and MR parameters whether calculated as mean values per
ROI or as pixel-by-pixel values within each ROI [106].
Model selection paradigm
Vasculature within a solid tumor exhibits a range of leaki-
ness and visualizing the enhancement patterns is not al-
ways reflective of these variations. Ability to segment and
quantify such variations is important since they can serve
as measures of loci of tumor aggressiveness, whereas
changes in their patterns can represent biomarkers of re-
sponse to treatment. Moreover, with the minimally inva-
sive CE-MRI techniques, longitudinal monitoring of such
features is possible. With its ability to act as a reliable
marker for tumor vascular permeability, Gadomer-17 was
selected as the MRCA of choice to image and segment
tumor vascular functional variations.
The rat 9 L gliosarcoma model was used in the studies
designed to describe the operating characteristics of MRI
estimates of tumor vascular permeability. An extended
Patlak plot model was employed to establish regions with:
(1) no vascular leakage (Model 1 with just plasma volume,
vp); (2) leakage with no backflux (Model 2, with vp and
forward volume transfer constant Ktrans); and (3) leakage
along with measurable back flux (vp, K
trans and kep). An
objective F statistic was used to segment these regions.
The prevailing vascular permeability conditions deter-
mined which model satisfies the F test requirement best,
thus eliminating selection bias. It should be noted, how-
ever, that in not just brain tumor models, but also in other
models of neurovascular disease, there is almost certainly
a broad range of microvascular permeabilities among and
within lesions. This range is the result of the diseaseprocesses and is essential for disease and treatment evalu-
ations. To this end, the simplicity of calculating influx pa-
rameters by the extended Patlak plots and the objective
application of F statistic to segment the different regions
were established by these observations [107].
While it was apparent that serial MR investigations are
possible in rat brain tumor models to evaluate treatment
effects, the model selection paradigm required further
confirmation to establish its sensitivity to mirror acute
treatment effects. The often-used glucosteroid dexametha-
sone was chosen for this purpose due to its known fast
action in decreasing peritumoral edema. Moreover, previ-
ous studies by Fenstermacher’s group had established the
basic vascular constants and effects of dexamethasone
using QAR [108]. Thus, the gold standard values were
readily available for the comparison. Gadomer-17 was used
for CE-MRI and a single, high dose of dexamethasone
(8 mg/kg) was used to achieve quick therapeutic effects.
The dose of dexamethasone was chosen based on previous
work on animal brain tumor models in which between 3
and 30 mg/kg of dexamethasone was shown to be effective
in lowering the interstitial tumor pressures and reducing
edema. After the first MRI estimate of permeability (‘Test’),
dexamethasone was administered intravenously. A second
permeability study (‘Retest’) was performed 90 min after
the administration of dexamethasone. Results demon-
strated that model selection effectively captured the effect
of dexamethasone on tumor vasculature [109]. Using sig-
nificantly fewer rats the data also confirmed an earlier work
of Fenstermacher and his colleagues [108].
Logan plot and measuring tumor response to therapy
After establishing the MRI operating characteristics and the
model selection paradigm for tumor evaluation, investiga-
tions were extended to examine their potential to serve as
biomarkers for the efficacy of interventions such as the use
of anti-angiogenic and anti-vascular agents, drugs for tumor
cell kill, and radiotherapy. An immunocompromised athy-
mic nude rat model of U251 glioblastoma along with a dual
echo-gradient echo dynamic contrast-enhanced (DCE)-MRI
were used for these studies. Their purpose was to measure
the increased cell packing density in tumors compared to
normal brain using DCE-MRI. Apparent diffusion coeffi-
cient (ADC) of water was already reported to correlate with
cell density. However, the group felt that it could develop a
DCE-MRI measure of interstitial volume fraction (also
known as porosity), changes in which may reflect alterations
in cell density and correlate that to histological measure-
ments of actual cell density in the ROIs. If achieved, this
could then be used to non-invasively measure the effects of
tumor cell kill agents. Thus, the objective of this study was
to test the hypothesis that tumor cellularity and DCE-MRI-
derived interstitial volume fraction (ve) and/or distribution
volume (VD) were correlated in experimental cerebral
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Logan graphical plot [111], DCE-MRI image sets during and
after the injection of a clinically used Gd contrast agent
Magnevist, were employed to estimate the parameters vp,
Ktrans, ve, and VD. This was most likely the first attempt to
apply the Logan graphical plot to DCE-MRI data. Unlike
the Patlak plot and the Standard Model, the Logan plot uses
the later part of the uptake curve (when the response func-
tion either does not change with the input function or is at
a nearly steady state) for calculations. As an additional con-
firmation, the cell density data were also compared with
ADC values from these experiments. The results demon-
strated that the Logan plot-estimated VD correlated with the
Standard Model’s vp + ve [112]. In addition, the parameters
ve and VD significantly and negatively correlated with tumor
cellularity. A significant correlation of cell density with ADC
values was also observed, although this relationship was not
as strong as those with DCE-MRI measures [112].
An interesting feature of these studies was the adaptation
of the AIF from the previous radiotracer experiments. An
accurate determination of the AIF is essential for precise
calculation of permeability parameters. Because of the diffi-
culty in directly estimating the AIF from the MRI data, a
radiotracer assay-based input function obtained from the
previous investigation [94] was used in the dynamic MRI
studies. This demonstrated that, starting at about two mi-
nutes after injection of CA, the radiotracer and MRI mea-
sures of blood concentrations of CA track each other very
well. It was assumed for this adaptation that: (1) no vascu-
lar leakage of CA occurred in the contralateral striatum,
and (2) the plasma volume of the caudate putamen was
1%. The integrated area of the radiotracer AIF was scaled
so that its area was 100 times that of the integrated area of
the average value of ΔR1(t) in the caudate putamen of the
opposite hemisphere.
Using the criteria established by such investigations, the
acute effects of cilengitide, an anti-angiogenic agent, on
tumor vascular permeability kinetics were measured.
These data showed that cilengitde had a vascular normal-
izing effect at about 8 h after administration. This finding
coincided with previous reports of increased treatment
efficacy when radiotherapy followed cilengitde after 8 h
[113]. The Logan plot was subsequently used to measure
the peritumoral fluid flow, which is known to lead to brain
swelling and edema that can be fatal. Pathophysiologically,
its severity may also represent increased tumor interstitial
fluid pressure (TIFP), a factor that impedes tumor drug
penetration and decreases treatment efficacy. However, at-
tempts to measure VD beyond the peritumoral rim always
resulted in a negative ‘y’ intercept of the Patlak curves. In
previous experiments on vascular permeability the ‘y’
intercept was positive and was considered to represent a
measure of plasma distribution volume vp of Gd-affected
protons. The negative values led to several discussions toresolve the problem and in another ‘Aha’ moment,
Fenstermacher and James Ewing realized that it was due to
the fact that the driving force beyond the tumor rim was
interstitial and not intravascular. The Gd-based Magnevist
in the peritumoral region was being carried with the edema
fluid toward normal brain. This suggestion once again has
led to extensive data analysis and formulation of hypoth-
eses about the tumor rim and the presumably normal,
adjacent brain and their probable roles in tumor perfusion
and TIFP.
Other studies
Along with the major research advances in cerebral ische-
mia and brain tumor pathophysiology, Fenstermacher and
his collaborators pursued many other small projects.
Together with Jae Ho Kim, Svend Freytag and Steve
Brown from Radiation Oncology at the Henry Ford
Hospital, Fenstermacher worked on optimizing adenovirus-
mediated suicide gene therapy for prostate cancer. They
developed a method based on the human sodium iodide
symporter (hNIS) that allowed for noninvasive monitoring
of adenoviral vectors and quantification of gene expres-
sion. High-resolution autoradiographs of prostate sec-
tions coupled with a 3D reconstruction of gene expression
were generated, demonstrating that the magnitude and
volume of gene expression could be quantified [114]. The
method demonstrated submillimeter resolution allowing
for precise measurements of gene expression magnitude
and volume in vivo [115]. Clinical trials on gene therapy
for prostate cancer followed these publications.
New animal models of ischemic stroke were also devel-
oped as a result of Fenstermacher’s other collaborative pro-
jects. Together with Ling Wei, Dennis Choi and Chung
Hsu, he investigated how the severity of stroke varies
among different mouse strains [116]. In addition, a new
technically challenging mini-stroke model was developed in
rat with Ling Wei and Thomas Woolsey [117]. This model
showed an exquisite structural and functional association
with barrel cortex and provided a technique for functional
testing of stroke treatments. A rat model of intracerebral
focal stroke resulting from the photothrombotic lesion was
also developed together with Toshihiko Kuroiwa, Guohua
Xi, Ya Hua and Richard Keep [118,119]. This model exhib-
ited a clearly defined ischemic boundary along with BBB
disruption. Although it was initially produced in the
striatum, a small, focal lesion could be reproduced in
any given brain region by changing the placement of the
fiber optic tip.
Aside from many experimental studies, Fenstermacher
also co-authored several theoretical papers. One of his most
important accomplishments in this area was to enhance our
understanding of the behavior of blood-borne water protons
under a magnetic field. This provided the basis for AST
measurements of CBF. In AST measurements, the protons
Chodobski et al. Fluids and Barriers of the CNS 2015, 12:1 Page 15 of 18
http://www.fluidsbarrierscns.com/content/12/1/1as they flow along the carotid arteries are subjected to a
magnetic field and their reorientation as they pass beyond
the field generates the signals for the measurement of flow.
Discussions on this topic led to publications [120-123],
which in turn formed the foundation for the papers on mul-
tiparametric and DCE-MRI measurements. A similar ap-
proach was later followed in the development of a neural
network method for semi-automated calculations for the
objective assessment of image data sets [123-125].
The distribution of water in brain always occupied Fen-
stermacher’s thoughts due to its crucial role in health and
disease and its significance as the basis for proton MRI.
Fundamental studies in stroke on ADC changes and their
relationship with simultaneous astrocyte swelling and
neuronal shrinking to explain such changes in terms of
cellular alterations were conducted in collaboration with
Marc Fisher, Kai-Feng Liu and the late Julio Garcia
[126-129].Conclusions
The various scientific accomplishments of Joseph
Fenstermacher discussed in this review were not neces-
sarily done in chronological order, but, rather, were
often performed simultaneously, frequently influencing
each other. The early works of Fenstermacher and col-
leagues on CBF, ECS, and the distributions of water and
radiotracers across the BBB evolved seamlessly into the
use of modern technologies, such as MRI and CE-MRI.
Techniques were borrowed from one application to de-
velop the tools for another project. Examples include, but
are not limited to, FITC-labeled RBC used both for tumor
blood flow studies and to estimate temporal evolution of
BBB damage in acute stroke, the MRI-CAs utilized both
in stroke and tumor studies, and the list goes on.
In the modern and fast developing world of science,
when researchers frequently specialize in a unique and
narrow discipline, scientists like Joseph Fenstermacher
are unusual. He represents a rapidly diminishing gener-
ation with a deep understanding of the principles of
physiology. Nowadays, many consider this discipline of
biomedical science as rather archaic and unattractive.
However, when a holistic approach to the problem, such
as systems biology, is needed and the understanding of
the basics of physiology is lacking, the use of even the
most advanced and sophisticated technologies to solve
the problem may not provide the correct answers. The
quest for a better insight into physiology of fluids and bar-
riers of the brain championed by Joseph Fenstermacher laid
the groundwork for many of us to build upon. Although he
retired in 2012 from the Henry Ford Hospital, he continues
to write manuscripts and consult on grant applications, and
stays in close touch with his colleagues. Jean-François
Ghersi-Egea and Tavarekere Nagaraja, the contributors tothis review, had the privilege to train with Fenstermacher at
different stages of his career.
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